
Correlia Biosystems
Correlia Biosystems is a YC Winter 2018 (W18) company. Based in Berkeley, CA, USA. Team of 16.
About Correlia Biosystems
Summary
Correlia Biosystems builds microfluidic blood-testing tools that quantify proteins and other biomolecules from a single microliter of sample. Its SimpleScan platform gives pharmaceutical researchers continuous protein expression monitoring across a sample run, replacing conventional endpoint assays that capture only a single snapshot. The technology also targets point-of-care diagnostics, expanding its reach beyond the lab.
Go-to-market
Pharmaceutical companies are the primary customers, acquiring the platform to generate richer proteomic datasets for drug research and development.
From the Y Combinator listing
Next-gen blood testing to provide 1000x more data to pharma companies
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
Facts
- Healthcare / Healthcare -> Diagnostics
- Berkeley, CA, USA
- 16
- Inactive
- Growth
Founders (3)
- Akwasi Apori
- Kursad Araz
- Samuel Tia
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works